ARTICLE | Clinical News
Clioquinol: Phase II/III discontinued
April 18, 2005 7:00 AM UTC
PBT will not initiate the Phase II/III PLACQUE trial to treat AD because of di-iodo impurities found during the clinical manufacturing process. The company believes the impurities are responsible for ...